Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pill aims to calm lupus skin flares in major trial

NCT ID NCT07332481

Recruiting now Disease control Sponsor: EMD Serono Research & Development Institute, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 4 times

Summary

This study tests an experimental pill called enpatoran for people with lupus who have active skin rashes. About 202 participants will receive either the drug or a placebo for 24 weeks, while continuing their usual treatments. The goal is to see if enpatoran can significantly reduce skin disease activity. This is a Phase 3 trial, meaning it is one of the final steps before possible approval.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUTANEOUS LUPUS ERYTHEMATOSUS (CLE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cutaneous lupus erythematosus discoid lupus erythematosus subacute cutaneous lupus erythematosus systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CUTANEOUS LUPUS ERYTHEMATOSUS (CLE) SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Contacts and locations

Locations

  • Advance Medical Research Center

    RECRUITING

    Miami, Florida, 33135, United States

  • Allen Arthritis

    RECRUITING

    Allen, Texas, 75013, United States

  • Arthritis Care of Texas

    RECRUITING

    Corpus Christi, Texas, 78415, United States

  • Arthritis and Rheumatology Research Institute PLLC

    RECRUITING

    Allen, Texas, 75013, United States

  • Clinical Research of West Florida, Inc.

    RECRUITING

    Tampa, Florida, 33606, United States

  • Cohen Medical Centers

    RECRUITING

    Thousand Oaks, California, 91360, United States

  • D&H National Research Centers, Inc.

    RECRUITING

    Tamarac, Florida, 33321, United States

  • Dermatology Research Associates - 300204025

    RECRUITING

    Los Angeles, California, 90045, United States

  • Diverse Clinical Research LLC

    RECRUITING

    Miami, Florida, 33175, United States

  • Emory University School of Medicine

    RECRUITING

    Atlanta, Georgia, 30303, United States

  • GNP Research at Mark Jaffe, MD

    RECRUITING

    Cooper City, Florida, 33024, United States

  • JCHO Chukyo Hospital - Dept of Dermatology

    RECRUITING

    Nagoya, Aichi-ken, 457-8510, Japan

  • Kanazawa University Hospital - Dept of Rheumatology/Immunology

    RECRUITING

    Kanazawa, Ishikawa-ken, 920-8641, Japan

  • Kantonsspital St. Gallen - Klinik f. Dermatologie, Venerologie u Allergologie

    RECRUITING

    Sankt Gallen, 9000, Switzerland

  • NHO Chibahigashi National Hospital - Dept of Allergy/Rheumatology

    RECRUITING

    Chiba, Chiba, 260-8712, Japan

  • Revival Research Institute, LLC

    RECRUITING

    Troy, Michigan, 48084, United States

  • Sapporo City General Hospital - Dept of Rheumatology/Immunology

    RECRUITING

    Sapporo, Hokkaido, 060-8604, Japan

  • St. Luke's International Hospital - Dept of Immunology/Allergy

    RECRUITING

    Chūōku, Tokyo-To, 104-8560, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.